pDCs are another key innate immune cell type involved in COVID-19 pathogenicity30, and DOCK2 expression was downregulated in pDCs from patients with COVID-19 (FC = 0.79, P = 0.019; Fig. 2k). The gene discussed is DOCK2; the disease is COVID-19.